National Employer Initiative on

Specialty Drugs & Biopharma

Employer Focused, Employer Driven

Study Shows Growth in Number of Drug “Super Spenders”

A small, yet rapidly growing segment of commercially insured US patients have drug costs of more than $250,000 each year, and this group could account for 15% of all drug expenditures in the next 5 years.

Read more.